Bottom line#
On September 28, 2026, the European Parliament’s Public Health Committee gave the go-ahead to a cancer-prevention report that prioritizes tobacco. Yet, its rules regarding nicotine specifically aim to restrict the lower-risk products smokers often use to quit. Sweden achieved the EU’s smoke-free goal 15 years early, and it did so by making exactly these products easily accessible. The irony is stark: its most emphatic message—that “prevention should be at the heart of the plan”—sits right next to proposals designed to make those very alternatives harder to access. That is the core contradiction. This piece lays out the evidence for what seems like a disastrous (mis)application of the precautionary principle.
What exactly did the health committee vote on?#
On September 28, 2026, the European Parliament’s Committee on Public Health (SANT) approved a report on implementing the European Beating Cancer Plan (BECA). They committed to allocating at least €10.05 billion for health in the upcoming EU budget, with €2.5 billion ring-fenced for cancer (Eunews). The measure passed with 27 votes in favour, 8 against, and 5 abstentions, setting the stage for a plenary vote expected in October or November 2026.
The same risk factors (tobacco, alcohol, diet, and obesity) permeate the cardiovascular-prevention strategy that the Parliament adopted two weeks prior (passed 545–47 with 75 abstentions). However, the two texts diverge sharply once nicotine enters the discussion.
“Prevention at the heart”—but which kind?#
Vlad Vasile-Voiculescu, the rapporteur from Renew, stated plainly that prevention “should be at the heart of the plan,” noting that roughly 40 percent of cancers could be avoided by tackling tobacco, alcohol, diet, and obesity. Shadow rapporteur Nicolás González Casares echoed this sentiment: “Europe treats too much and prevents too little.”
All of that is accurate. Smoking remains the single largest preventable cause of cancer in the EU. The contradiction lies in what the text proposes to do about it.
Rather than distinguishing between combustible tobacco (the real harm) and lower-risk substitutes (the exit strategy), the report calls for urgently extending EU tobacco legislation to e-cigarettes, heated tobacco products, and nicotine pouches. It proposes adding restrictions on flavorings, plain packaging, mandatory ingredient labeling, a ban on online sales to minors, and higher minimum excise duties. Green MEP Tilly Metz advocated for “a European ban” on high-concentration nicotine pouches, though she offered no definition for what “high concentration” entails. We shouldn’t forget that Luxembourg recently set a 0.048 mg/pouch limit, rendering the product useless for smokers. Socialist MEP Casares argued flavorings “are designed to attract children” and demanded a Europe-wide ban.
In practice, however, the proposed rules treat all nicotine products as if they carry comparable cancer risks, a position that has been presented publicly by EU officials (including the health commissioner) but is not supported by the available evidence.
Why does restricting smoking substitutes contradict a prevention-first strategy?#
Smoking is the single biggest cancer risk in the EU, so any product helping people move off cigarettes directly serves the plan’s own goal. Tobacco caused nearly 20% of EU cancer deaths in 2021 (Euronews)), and the Commission estimates tobacco causes about 700,000 deaths annually in the EU (European Commission). BECA’s own target is fewer than 5% tobacco users by 2040, down from about 25% in 2021 (European Commission communication).
The paradox is this: Instead of addressing smoking and expanding the methods and tools available to smokers to help them quit, we treat lower-risk nicotine products—those used as alternatives to smoking—as a threat that must be curtailed. With such a “prevention” strategy, which ought to be grounded in reducing smoking, how many smokers will be forced to keep smoking?
What did Sweden do differently?#
Sweden made low-risk oral nicotine cheap, legal, and widely available, becoming the first country in Europe to fall below 5% daily smoking.
| Indicator | Sweden | EU |
|---|---|---|
| Daily smokers, 2025 | 4.8% (down from 16% in 2003) | 24% average in 2023 |
| Smoke-free target | Reached 2025 | 2040 (BECA) |
| Dominant substitute | Snus and pouches | Mostly none |
Sweden was the world’s first nation to dip below the 5 percent daily-smoking threshold—the WHO’s definition of “smoke-free”—roughly 15 years before the EU’s own 2040 target. It achieved this without banning pouches or imposing heavy taxes on snus. It succeeded because snus and, more recently, nicotine pouches were available, accessible, and taxed lower than cigarettes, providing adult smokers a practical exit.
So what is the EU’s response in the same report? Extend tobacco rules to pouches, restrict flavors, raise taxes, and consider bans. The least harmful category—pouches, which have a risk profile closer to approved nicotine-replacement therapies than to cigarettes—is being targeted as if it were the threat.
This isn’t a minor drafting choice. It is a strategic error that ignores the only large-scale, real-world demonstration in Europe of how to drive smoking down quickly.
The Swedish public health agency notes that snus and pouches are taxed far lower than tobacco, making them affordable for cost-sensitive groups (Folkhälsomyndigheten review, PMC). And that would work for the whole EU: an analysis of 2002 WHO data estimated 54% fewer male lung cancer deaths in the EU if every country matched Swedish men (Rodu & Cole, Scand J Public Health).
What counts as success? The measurement problem#
Depending on what is counted, Sweden’s success can look like failure. The WHO “smoke-free” benchmark counts daily smokers. Eurostat’s grouping of tobacco, e-cigarettes, and nicotine pouches puts Sweden at 23.9% daily use, the second highest in the EU (Euronews). But such an approach makes no sense, and it only serves to hide the unique success of Sweden. Public health is about preventing disease and death, not about judging behaviors from a “moralistic” perspective.
What gets lost in the framing#
Regarding alcohol, the report’s framing is more nuanced: clearly visible health information on drinks, no blanket ban, and a zero-consumption target only for minors. MEP Tilly Metz explicitly rejected prohibition: “I am not in favour of a ban on alcohol. That is not the solution.” The text treats alcohol as a risk to manage, not eliminate.
Tobacco substitutes receive no equivalent nuance. No section asks how many smokers switched to harm reduction products. There is no mention of Sweden’s smoking rate. Nor is there reference to the substantial body of epidemiological evidence showing that combustion—not nicotine—drives cancer, a fact known for 50 years. The irony is sharpest in Voiculescu’s own words: “Europe treats too much and prevents too little.” But prevention means keeping people from starting or helping them stop smoking, not making the exit harder.
How risky are nicotine pouches compared with nicotine replacement therapy?#
Nicotine pouches appear to sit at the low end of the risk spectrum, adjacent to NRT, though they are not risk-free and long-term outcome data are still missing. The most complete recent synthesis is a February 2026 narrative review in Internal and Emergency Medicine. It covers composition, toxicology, nicotine delivery, cessation, and public health impact, concluding that pouches have a risk profile likely adjacent to pharmaceutical NRT. It adds that modern pouches deliver nicotine more slowly than a cigarette, enough to ease cravings and displace smoking, and that clinicians could consider them for smokers unable or unwilling to quit. It also reports that current population data suggest pouches are unlikely to become a gateway to smoking, while calling for continued monitoring.
Voiculescu argues that no nicotine product has been shown safe over a lifetime. That is true, but it is also true of NRT, which regulators and clinicians routinely recommend, with some countries (UK and USA) suggesting long-term use to stay away from smoking. So, the relevant comparison for a smoker is continued smoking.
Do flavours help smokers switch?#
Most available evidence, all from e-cigarette observational studies, links non-tobacco flavors to better odds of quitting smoking. Adults who stopped smoking with vaping products mostly use fruit and dessert flavors, not tobacco. In a survey of 51,641 former smokers, about 48% named fruit and 37% dessert or bakery flavors as their main flavor when they quit, against just 2% for tobacco. In another study of 69,233 adult vapers, tobacco was the most-used flavor for only 2% at the time of the survey. A five-year US cohort found 98.2% used more than one flavor regularly and only 11.2% preferred tobacco.
Other cohort studies point the same way. Compared with tobacco flavors, the odds of quitting were higher among users of:
- non-tobacco flavors in general, in a US national cohort (Friedman & Xu, JAMA Network Open, 2020), with the presentation reporting more than double the odds;
- mint and mango, 37% higher odds (Russell et al., Harm Reduction Journal, 2019);
- sweet flavors, 60% higher odds, across five countries (Li et al., Nicotine & Tobacco Research, 2021);
- mint or menthol, 90% higher, and other non-tobacco flavors, 70% higher, while unflavored or tobacco-flavored products showed no advantage over not vaping (Mok et al., Nicotine & Tobacco Research, 2022).
A systematic review of 104 adult studies concluded that variety in flavors and higher nicotine strength make e-cigarettes more appealing and could help smokers switch completely, urging regulators to weigh the effect on smokers (Gades et al., Nicotine & Tobacco Research, 2022).
Are flavours what attracts young people?#
Flavors are appealing to young people, but US data shows they rank well behind friends, curiosity, and stress as reasons for starting. In the 2023 National Youth Tobacco Survey, 50% of adolescent e-cigarette users cited a friend’s use and 41% curiosity, while only 12% cited flavor availability, the 7th most popular reason. Other surveys weigh flavors more heavily: in Great Britain 85% of young current users used a flavored device, and liking the flavors was the most common reason among 11–17-year-old smokers who vaped (eClinicalMedicine, 2022). The gateway concern is literally rejected based on evidence from the US: current smoking among high-school students fell from 15.8% in 2011 to 1.4% in 2025 as vaping became popular.
Do flavour bans work?#
The Danish experience suggests flavour bans can miss their target. Denmark banned all e-cigarette flavors except menthol and tobacco in April 2022. By 2024, use among 15–29-year-olds had risen from 7% to 12%, and 63% of users reported fruit flavors, which the ban was meant to remove, according to a report of the Danish Health Authority survey (Vejpkollen, trade press). A University of Michigan and Georgetown analysis likewise warned that flavor restrictions could increase smoking and create an illicit market (Cadham et al., BMC Public Health, 2022).
The same Danish data show youth smoking at record lows, so the ban’s effect on smoking itself is unclear. Another argument is that flavorings come from the food industry, so a ban can restrict labeling and marketing but not the availability of the ingredients themselves.
Is the EU actually banning nicotine pouches?#
Not yet at EU level. The committee text asks for flavor restrictions, plain packaging, and higher taxes rather than an outright prohibition, and the Commission is expected to propose revisions to the Tobacco Products Directive by the end of 2026 (EU Reporter). Member states are split: France, Belgium, and the Netherlands push for tougher measures, while Italy and Greece are more cautious. The Commission’s tax proposal would also extend harmonized excise duties to pouches. France has already adopted a national pouch ban, threatening with fines and imprisonment for possession. An unprecedented situation for a western country, member of the EU.
Flavor bans and strength caps can narrow a market without formally prohibiting it, so the practical question is whether adult smokers will still find a pouch they will switch to.
What would proportionate regulation look like?#
Evidence-consistent options include age limits enforced online and in shops (such measures have already been implemented in many countries), marketing restrictions aimed at young people, quality standards, and taxes (or no taxation at all) that ensures low-risk products are by far cheaper than cigarettes. Sweden’s tax gap is the clearest example of the last point. These address the genuine youth-uptake concern without removing the route that worked for adult smokers.
When will the European Parliament vote on the cancer plan report?#
A plenary vote is expected between October and November 2026 (Eunews).
Key takeaways#
- The SANT Committee adopted the BECA implementation report by 27 votes to 8, with 5 abstentions; a plenary vote is expected in October–November 2026 (Eunews).
- Sweden’s daily smoking fell from 16% in 2003 to 4.8% in 2025, below the 5% “smoke-free” threshold (CAN report via Medical Xpress).
- Tobacco control is among the highest-return health investments there is: WHO modelling puts returns from its “best buys” at roughly US$7 per US$1 by 2030 (WHO).
- The risk profile of nicotine pouches is close to nicotine replacement therapy (NRT), but long-term health data do not yet exist.
- Flavours matter to adult switchers: in vaping studies, non-tobacco flavours are linked to higher odds of quitting smoking, but the evidence is observational and none of it is from pouches.
- No EU-wide pouch ban is on the table yet, but the Parliament report calls for flavour restrictions and some MEPs openly favour a ban on high-strength pouches.
Frequently asked questions#
**Are nicotine pouches absolutely safe?
Nicotine pouches are not risk-free, but analyses place their toxicant profile near NRT and far below cigarette smoke (Farsalinos, 2026).
**Did Sweden become smoke-free only because of snus?
Snus and pouches were central, supported by low taxation and wide availability, but Sweden also had broad smoke-free-environment policies (Folkhälsomyndigheten review).
**When will the European Parliament vote on the cancer plan report?
A plenary vote is expected between October and November 2026 (Eunews).
**Do nicotine pouches help smokers quit?
Trials reviewed in 2025 suggest pouches may reduce cigarette consumption, with effects similar to snus or nicotine gum, though the evidence base is still small (Heshmati et al.). Most of the evidence is coming from population studies in Sweden, that show snus had a substantial effect in reducing smoking in the country.
**Do flavour bans reduce youth nicotine use?
Not reliably. Denmark’s 2022 flavour ban was followed by a rise in use among 15–29-year-olds from 7% to 12% by 2024, with most users still reporting fruit flavours (Vejpkollen, reporting the Danish Health Authority survey).
**Do flavours help smokers quit?
In studies of vaping products, yes, on average, but the evidence is observational and mixed, and there is no equivalent study for pouches (Systematic review, 2023; Friedman & Xu, 2020).
Sources#
- Eunews, “Food, alcohol, and tobacco: the European Parliament’s crackdown”, 28 Sept 2026: https://www.eunews.it/en/2026/09/28/cifood-alcohol-tobacco-ep-crackdown/
- Swedish Council for Information on Alcohol and Other Drugs (CAN) report, via Medical Xpress, May 2026: https://medicalxpress.com/news/2026-05-sweden-free-goal-daily-smokers.html
- Public Health Agency of Sweden review, “Swedish tobacco policy: key learnings”: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11659985/
- Rodu B, Cole P. Lung cancer mortality: comparing Sweden with other EU countries. Scand J Public Health 2009: https://pubmed.ncbi.nlm.nih.gov/19535408/
- Heshmati et al. Nicotine pouches and smoking cessation outcomes: systematic review of randomized trials. Addiction, 2025: https://onlinelibrary.wiley.com/doi/10.1111/add.70193
- Nicotine pouches: an aid in smoking cessation, or a new public health hazard? (narrative review): https://pubmed.ncbi.nlm.nih.gov/41686395/
- WHO, NCD and tobacco control investment cases (2024): https://cdn.who.int/media/docs/default-source/ncds/investment-cases-draft-paper-for-the-2024-financing-dialogue.pdf?sfvrsn=12a39c1b_3
- European Commission, Europe’s Beating Cancer Plan communication: https://www.drugsandalcohol.ie/42354/
- European Commission, smoke-free environments recommendation, Sept 2024: https://commission.europa.eu/news-and-media/news/commission-proposes-extend-coverage-smoke-free-environments-2024-09-17_en
- Euronews, EU cancer risk-factor study, Feb 2025: https://euronews.com/health/2025/02/04/eu-can-dodge-millions-of-cancers-by-hitting-tobacco-alcohol-reduction-targets-study-claims
- Euronews, EU smoking and vaping prevalence, Sept 2026: https://www.euronews.com/my-europe/2026/09/01/cigarettes-are-on-the-decline-in-the-eu-but-how-popular-are-smoking-and-vaping-still
- EU Reporter, “Brussels prepares sweeping reset of nicotine policy”, April 2026: https://www.eureporter.co/health/2026/04/07/brussels-prepares-sweeping-reset-of-nicotine-policy-as-battle-lines-harden/
- Tobacco Insider, “Tobacco Regulation: European Union”: https://tobaccoinsider.com/tobacco-regulation-european-union/
- cigprices.com, nicotine pouch legality in Europe, 2026 (trade source; verify against official French texts): https://cigprices.com/en/blog/sachets-nicotine-legalite-europe-2026
